| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.choksilab.com | |
| Market Cap | 22.75 Cr. | |
| Enterprise Value(EV) | 56.92 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 3.53 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 9.24 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 45.85 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 25.99 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 1.26 | Calculated using Price: 32.66 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.70 Cr. | 6,965,263 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services. | ||
| 1 Day |
|
|
| 1 Week |
|
-1.95% |
| 1 Month |
|
-19.28% |
| 3 Month |
|
-10.79% |
| 6 Month |
|
-4.53% |
| 1 Year |
|
+24.62% |
| 2 Year |
|
+343.01% |
| 5 Year |
|
+25.58% |
| 10 Year |
|
+277.89% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 5.95 | 4.45 | 3.67 | 4.34 | 6.19 | 6.90 | -17.57 | -13.74 | 1.16 | |
| Return on Capital Employed (%) | 9.42 | 9.39 | 7.32 | 8.41 | 10.49 | 10.14 | -8.27 | 0.02 | 6.75 | |
| Return on Assets (%) | 3.19 | 2.31 | 1.80 | 2.15 | 3.16 | 3.20 | -6.53 | -4.06 | 0.32 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 20 | 19 | 20 | 21 | 22 | 24 | 20 | 18 | 18 | 18 | |
| Non Curr. Liab. | 8 | 6 | 9 | 5 | 7 | 18 | 29 | 31 | 30 | 29 | |
| Curr. Liab. | 10 | 12 | 14 | 14 | 16 | 13 | 14 | 16 | 16 | 15 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 39 | 38 | 43 | 41 | 45 | 55 | 64 | 65 | 63 | 62 | |
| Non Curr. Assets | 27 | 23 | 28 | 28 | 30 | 39 | 47 | 52 | 49 | 48 | |
| Curr. Assets | 11 | 15 | 15 | 13 | 15 | 16 | 17 | 13 | 14 | 14 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 39 | 38 | 43 | 41 | 45 | 55 | 64 | 65 | 63 | 62 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 20 | 22 | 22 | 29 | 31 | 34 | 28 | 26 | 30 | 35 | |
| Other Income | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 20 | 23 | 22 | 30 | 32 | 34 | 28 | 26 | 30 | 35 | |
| Total Expenditure | -16 | -17 | -17 | -24 | -25 | -26 | -25 | -22 | -21 | -23 | |
| PBIDT | 4 | 6 | 5 | 6 | 7 | 8 | 3 | 5 | 9 | 12 | |
| Interest | -1 | -2 | -1 | -1 | -2 | -2 | -2 | -3 | -3 | -3 | |
| Depreciation | -2 | -3 | -3 | -3 | -3 | -4 | -5 | -5 | -5 | -5 | |
| Taxation | 0 | -1 | 0 | 0 | -1 | -1 | 2 | 0 | 0 | -1 | |
| Exceptional Items | -2 | ||||||||||
| PAT | 1 | 1 | 1 | 1 | 1 | 2 | -4 | -3 | 0 | 2 | |
| Adjusted EPS | 2 | 1 | 1 | 1 | 2 | 2 | -6 | -4 | 0 | 4 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 2 | 4 | 2 | 7 | 7 | 6 | 7 | 3 | 6 | 8 | |
| Cash Fr. Inv. | -3 | -6 | -1 | -7 | -2 | -5 | -10 | -14 | -8 | -3 | |
| Cash Fr. Finan. | 0 | 1 | -1 | 1 | -5 | -1 | 2 | 11 | 2 | -5 | |
| Net Change | 0 | -1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
|
Mon, 13 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2023 Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 We Wish to inform you that following business were transacted at the meeting of the Board of Directors of the Company held on Monday the day of 13th February 2023 at the registered office of the Company situated at Survey No 9/1 Near Balaji Tulsiyana Industrial Estate Gram Kumedi Indore 452010. |
|
Mon, 13 Feb 2023
Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2022 Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 We Wish to inform you that following business were transacted at the meeting of the Board of Directors of the Company held on Monday the day of 13th February 2023 at the registered office of the Company situated at Survey No 9/1 Near Balaji Tulsiyana Industrial Estate Gram Kumedi Indore 452010. |
|
Mon, 13 Feb 2023
Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2022 Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 We Wish to inform you that following business were transacted at the meeting of the Board of Directors of the Company held on Monday the day of 13th February 2023 at the registered office of the Company situated at Survey No 9/1 Near Balaji Tulsiyana Industrial Estate Gram Kumedi Indore 452010. (Signed Copy) |
| Fri, 24 Mar 2023 |
High Delivery Percentage
|
Opening at Low
|
Making Lower Lows for 3 days
|
Close Below Last Month Low
|
High Decrease in 1 Month
|
Equities
M.F.
Sectors